Evidence map›Paper›PMID 28357499›Full record

ReviewCurrent genetics2017

Mrc1/Claspin: a new role for regulation of origin firing.

Hisao Masai, Chi-Chun Yang, Seiji Matsumoto

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Claspin and Cancer: Where Are We Now?International journal of molecular sciences · 2025
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Implications ofCancers · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hisao MasaiDepartment of Genome Medicine, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan. masai-hs@igakuken.or.jp.
Chi-Chun YangDepartment of Genome Medicine, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan.
Seiji MatsumotoDepartment of Genome Medicine, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mrc1 and its vertebrate homologue Claspin serve as a mediator for replication stress checkpoint signaling, receiving the signal from Mec1/Rad3/ATR sensor kinase and transmitting it to the effector Rad53/Cds1/Chk1 kinase. They are likely to be a part of the replisome and facilitate the S-phase progression by promoting replication fork progression. Recent reports on Mrc1/Claspin indicate their new role in regulating the replication initiation through interaction with Cdc7, a key conserved serine-threonine kinase that triggers firing at each replication origin. Mrc1/Claspin has a specific domain that specifically interacts with Cdc7, and this domain is involved also in intramolecular interaction with its N-terminal segment. Mechanisms for novel regulation of origin firing and its timing through recruitment of Cdc7 to Mrc1/Claspin will be discussed.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCell Cycle ProteinsDNA ReplicationHumansMammalsMembrane GlycoproteinsMutationPhosphotransferases (Alcohol Group Acceptor)Protein BindingProtein Interaction Domains and MotifsProtein Serine-Threonine KinasesReceptors, ImmunologicReplication OriginSchizosaccharomycesSignal TransductionAdaptor Proteins, Signal TransducingCDC7 protein, humanCell Cycle ProteinsCLSPN protein, humanhomoserine kinaseMembrane GlycoproteinsMRC1 protein, humanPhosphotransferases (Alcohol Group Acceptor)Protein Serine-Threonine KinasesReceptors, ImmunologicCdc7 kinaseClaspinIntramolecular interactionMrc1Origin firingReplication timing

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.